RecruitingNot ApplicableNCT07444645
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Sponsor
M.D. Anderson Cancer Center
Enrollment
20 participants
Start Date
Aug 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This single-arm prospective study will compare CT-based tumor-to-normal ratio (TNR) measurements obtained using TriNav versus endhole microcatheters.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Y90 Microsphere Therapy for people with liver and tumor. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEY90 Microsphere Therapy
Given by injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07444645
Related Trials
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT066909571 location
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NCT066907361 location
FAPI PET/CT in Various FAP-Related Disease Patients
NCT066880711 location
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT067256931 location
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
NCT061082321 location